AMERI Holdings Amalgamation Partner Jay Pharma Reports IRB Approval For Testing Proprietary CBD Formulation In Brain Cancer

Final approval is anticipated in summer 2020 to initiate phase I/II study in Glioblastoma Multiforme. The study will enroll 40 patients with recurrent or progressive GBM tumors who are currently undergoing chemotherapy.